drugset / Trial / NCT04355728
Use of UC-MSCs for COVID-19 Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this research study is to learn about the safety and efficacy of human umbilical cord derived Mesenchymal Stem Cells (UC-MSC) for treatment of COVID-19 Patients with Severe Complications of Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS).
Timeline
- Start
- 2020-04-25
- Primary completion
- 2020-10-31
- Completion
- 2020-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 1e+08 cells | Intravenous |
| Background | Heparin | Other / unclassified | — | — |